发明名称 |
VAEVSPLASMINOGENAKTIVATOR-ANALOGER MED FORBEDRET AKTIVITET |
摘要 |
Tissue plasminogen activator (t-PA) analogues have at least one substitution in the growth factor (GF) domain that at least partially reduces hepatic receptor binding without substantially jeopardising physico-chemical stability in blood or fibrinolytic activity. This results in a longer plasma half life. Substitutions in the beta-sheet encompassing residues 63-72, especially at Leu 66 and/or Tyr 67 and/or Phe 68, are particularly preferred. |
申请公布号 |
DK305490(A) |
申请公布日期 |
1991.02.20 |
申请号 |
DK19900003054 |
申请日期 |
1990.12.21 |
申请人 |
BRITISH BIO-TECHNOLOGY LIMITED |
发明人 |
EDWARDS, RICHARD MARK;DAWSON, KEITH;FALLON, ANTHONY;CRAIG, STEWARD |
分类号 |
C12N15/09;A61K38/00;A61K38/46;A61P7/02;C07H21/04;C12N1/00;C12N9/64;C12N9/72;C12N15/58;(IPC1-7):C12N9/64 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|